Improving access to abortion medications.

SB 5917 authorizes Washington's Department of Health to operate a program distributing abortion medications (like mifepristone and misoprostol) to healthcare providers and entities offering reproductive health care, including abortion services. The bill requires medications to be sold at cost - capped at list price plus a $5 fee per dose for secure storage and delivery - and prioritizes bulk distribution to clinics and hospitals. It exempts the state from needing a wholesaler's license for this program under existing law and mandates that medications only be used for reproductive health care. The policy directly affects healthcare providers and facilities that offer abortion or pregnancy-related care in Washington State.